CROWTHER BRUCE K 4
4 · NEOGENOMICS INC · Filed Jun 10, 2021
Insider Transaction Report
Form 4
CROWTHER BRUCE K
Director
Transactions
- Exercise/Conversion
Common Stock
2021-06-08$11.60/sh+3,017$34,997→ 62,581 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-08−3,017→ 0 totalExercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-08−4,269→ 0 totalExercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-08−10,000→ 0 totalExercise: $7.27Exp: 2022-05-25→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-08−3,448→ 0 totalExercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - Exercise/Conversion
Common Stock
2021-06-08$7.27/sh+10,000$72,700→ 59,564 total - Exercise/Conversion
Common Stock
2021-06-08$22.52/sh+4,269$96,138→ 66,850 total - Sale
Common Stock
2021-06-08$41.46/sh−20,734$859,632→ 49,564 total - Exercise/Conversion
Common Stock
2021-06-08$28.54/sh+3,448$98,406→ 70,298 total
Holdings
- 3,714
Stock Option (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying)
Footnotes (1)
- [F1]On May 25, 2017, Mr. Crowther was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.